Nra-quetiapine Xr: Some Lots Exceed The Intake Limit Of N-nitroso-desalkyl-quetiapine (ndaq)

Quetiapine XR Recall Summary Certain lots of NRA-Quetiapine XR contain higher-than-acceptable levels of N-nitroso-desalkyl-quetiapine (NDAQ), a chemical impurity. This medication is distributed across Canada and is used to treat psychiatric conditions. The recall affects specific batches of this extended-release tablet formulation.

Product

NRA-Quetiapine XR

Reason

Product quality

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2025-04-11

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/351bcc8d-26f1-4801-ab7f-c831a092246d